[B! L452R] stella_nfã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

stella_nf id:stella_nf

L452Rã«é–¢ã™ã‚‹stella_nfã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (3)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

æ±äº¬éƒ½ ã‚¤ãƒ³ãƒ‰ã§è¦‹ã¤ã‹ã£ãŸå¤‰ç•°ã‚¦ã‚¤ãƒ«ã‚¹ã«ã‚ˆã‚‹ã‚¯ãƒ©ã‚¹ã‚¿ãƒ¼ç™ºç”Ÿ | NHKãƒ‹ãƒ¥ãƒ¼ã‚¹
æ±äº¬éƒ½ã¯ã‚¤ãƒ³ãƒ‰ã§è¦‹ã¤ã‹ã£ãŸã€ŒL452Rã€ã®å¤‰ç•°ãŒã‚ã‚‹ã‚¦ã‚¤ãƒ«ã‚¹ã«10æ³æœªæº€ã¨10ä»£ã€ãã‚Œã«40ä»£ã®ç”·å¥³åˆã‚ã›ã¦10äººãŒæ„ŸæŸ“ã—ãŸã“ã¨ã‚’9æ—¥ã€æ–°ãŸã«ç¢ºèªã—ãŸã¨ç™ºè¡¨ã—ã¾ã—ãŸã€‚éƒ½å†…ã§1æ—¥ã«ç¢ºèªã•ã‚ŒãŸæ•°ã¨ã—ã¦ã¯ã“ã‚Œã¾ã§ã§æœ€ã‚‚å¤šããªã‚Šã¾ã—ãŸã€‚ 10äººã¯8æ—¥ã«æ„ŸæŸ“ãŒç¢ºèªã•ã‚ŒãŸç”·åä¸å¦ç”ŸãŒé€šã†ä¸å¦æ ¡ã®åŒç´šç”Ÿ4äººã¨ãã®å®¶æ—6äººã§ã€éƒ½ã«ã‚ˆã‚Šã¾ã™ã¨ã€åŒç´šç”Ÿã‚‰ã¯ç™»ä¸‹æ ¡ãªã©ã§è¡Œå‹•ã‚’ã¨ã‚‚ã«ã—ã¦ã„ãŸã¨ã„ã†ã“ã¨ã§ã™ã€‚ ä¿å¥æ‰€ã¯ã€ŒL452Rã€ã®å¤‰ç•°ãŒã‚ã‚‹ã‚¦ã‚¤ãƒ«ã‚¹ã«ã‚ˆã‚‹ã‚¯ãƒ©ã‚¹ã‚¿ãƒ¼ãŒç™ºç”Ÿã—ãŸã¨æ–å®šã—ã¾ã—ãŸã€‚ éƒ½ã«ã‚ˆã‚Šã¾ã™ã¨ã€ŒL452Rã€ã®å¤‰ç•°ãŒã‚ã‚‹ã‚¦ã‚¤ãƒ«ã‚¹ã§åŒå±…ã—ã¦ã„ãªã„äººã®ã‚¯ãƒ©ã‚¹ã‚¿ãƒ¼ãŒç™ºç”Ÿã—ãŸã®ã¯åˆã‚ã¦ã§ã™ã€‚ 10äººå…¨å“¡è»½ç—‡ã§è‡ªå®…ã§ç™‚é¤Šã—ã¦ã„ã‚‹ã¨ã„ã†ã“ã¨ã§ã™ã€‚ ä¿å¥æ‰€ã¯ã“ã®ä¸å¦æ ¡ã®ç”Ÿå¾’ã¨æ•™å“¡100äººç¨‹åº¦ã®æ¤œæŸ»ã‚’é€²ã‚ã¦ã„ã¾ã™ã€‚ ã“ã‚Œã¾ã§ã®èª¿æŸ»ã§ã¯ã€ã“ã®å¦æ ¡ã®é–¢ä¿‚è€…ã§æµ·å¤–ã¸ã®æ¸¡èˆªæ´ãŒã‚ã‚‹äººã®å ±å‘Šã¯ãªã„ã¨ã„ã†ã“ã¨ã§ã€ä¿å¥æ‰€ã¯æ„ŸæŸ“çµŒè·¯
stella_nf 2021/06/09
â€œ8æ—¥ã«æ„ŸæŸ“ãŒç¢ºèªã•ã‚ŒãŸç”·åä¸å¦ç”ŸãŒé€šã†ä¸å¦æ ¡ã®åŒç´šç”Ÿ4äººã¨ãã®å®¶æ—6äººâ€

medical

disease

COVID-19

L452R

deltavariant
ãƒªãƒ³ã‚¯
éƒ½å†…ã§ã‚¤ãƒ³ãƒ‰ã®å¤‰ç•°ã‚¦ã‚¤ãƒ«ã‚¹5äººæ¤œå‡º 4äººã¯æ¸¡èˆªæ´ãªã | NHKãƒ‹ãƒ¥ãƒ¼ã‚¹
ã‚¤ãƒ³ãƒ‰ã§å ±å‘Šã•ã‚Œã¦ã„ã‚‹æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®å¤‰ç•°ã‚¦ã‚¤ãƒ«ã‚¹ã«ã¤ã„ã¦ã€æ±äº¬éƒ½ã®ã€Œå¥åº·å®‰å…¨ç ”ç©¶ã‚»ãƒ³ã‚¿ãƒ¼ã€ãŒåˆ†æžã—ãŸçµæžœã€ã“ã‚Œã¾ã§ã«5äººã®æ¤œä½“ã‹ã‚‰æ¤œå‡ºã•ã‚ŒãŸã“ã¨ãŒã‚ã‹ã‚Šã¾ã—ãŸã€‚ã“ã®ã†ã¡4äººã¯æ¸¡èˆªæ´ãŒãªãã€æ¸¡èˆªæ´ãŒã‚ã‚‹äººã®æ¿ƒåŽšæŽ¥è§¦è€…ã§ã‚‚ãªã„ã¨ã„ã†ã“ã¨ã§ã™ã€‚ éƒ½ã®å¥åº·å®‰å…¨ç ”ç©¶ã‚»ãƒ³ã‚¿ãƒ¼ã¯4æœˆ1æ—¥ä»¥é™ã«ã‚»ãƒ³ã‚¿ãƒ¼ã§å—ã‘ä»˜ã‘ãŸæ¤œä½“ã®ã†ã¡ã€æ¤œæŸ»å¯èƒ½ãªé‡ãŒæ®‹ã£ã¦ã„ã‚‹ã‚‚ã®ã‚’æŠ½å‡ºã—ã€ã‚¤ãƒ³ãƒ‰ã§å ±å‘Šã•ã‚Œã¦ã„ã‚‹å¤‰ç•°ã‚¦ã‚¤ãƒ«ã‚¹ã‹ã©ã†ã‹ã‚’åˆ†æžã—ã¾ã—ãŸã€‚ ãã®çµæžœã€5äººã®æ¤œä½“ã‹ã‚‰æ¤œå‡ºã•ã‚ŒãŸã¨ã„ã†ã“ã¨ã§ã™ã€‚ ã“ã®ã†ã¡4äººã®æ¤œä½“ã‹ã‚‰ã¯ã€ŒL452Rã€ã¨ã€ŒE484Qã€ã¨ã„ã†2ã¤ã®å¤‰ç•°ã‚’ä½µã›æŒã£ã¦ã„ã‚‹ã“ã¨ãŒç¢ºèªã•ã‚Œã¾ã—ãŸãŒã€æ®‹ã‚‹1äººã®æ¤œä½“ã‹ã‚‰ã¯ã€ŒL452Rã€ã®å¤‰ç•°ãŒã‚ã‚‹ã‚‚ã®ã®ã€ŒE484ã€ã«å¤‰ç•°ã¯ãªã„ã¨ç¢ºèªã•ã‚ŒãŸã¨ã„ã†ã“ã¨ã§ã™ã€‚ 5äººã®ã†ã¡1äººã¯æµ·å¤–ã¸ã®æ¸¡èˆªæ´ãŒã‚ã‚Šã¾ã™ãŒã€æ®‹ã‚Šã®4äººã¯æ¸¡èˆªæ´ãŒãªãã€æ¸¡èˆªæ´ãŒã‚ã‚‹äººã®æ¿ƒåŽšæŽ¥è§¦è€…ã§ã‚‚ãªã„ã¨ã„ã†ã“ã¨ã§
stella_nf 2021/05/06
â€œæ¸¡èˆªæ´ãŒã‚ã‚‹äººã®æ¿ƒåŽšæŽ¥è§¦è€…ã§ã‚‚ãªã„ã¨ã„ã†ã“ã¨ã§ã™ã€‚â€

medical

disease

COVID-19

L452R

E484Q

deltavariant
ãƒªãƒ³ã‚¯
ã€ç‹¬è‡ªã€‘ç±³ã§æµè¡Œã®å¤‰ç•°åž‹ã€æ—¥æœ¬äººã®ï¼–å‰²ã¯å…ç–«åŠ¹æžœä½Žä¸‹ã‹â€¦æ±å¤§ãªã©è§£æž : ç§‘å¦ãƒ»ï¼©ï¼´ : ãƒ‹ãƒ¥ãƒ¼ã‚¹
ç™ºè¨€å°ç”º ã€Œç™ºè¨€å°ç”ºã€ã¯ã€èªå£²æ–°èžãŒé‹å–¶ã™ã‚‹å¥³æ€§å‘ã‘æŽ²ç¤ºæ¿ã§ã€å¥³æ€§ã®ãƒ›ãƒ³ãƒãŒåˆ†ã‹ã‚‹ã€Œãƒãƒƒãƒˆç‰ˆäº•æˆ¸ç«¯ä¼šè°ã€ã®å ´ã§ã™ã€‚ ãƒ¨ãƒŸãƒ‰ã‚¯ã‚¿ãƒ¼ yomiDr.ï¼ˆãƒ¨ãƒŸãƒ‰ã‚¯ã‚¿ãƒ¼ï¼‰ã¯ã€èªå£²æ–°èžã®åŒ»ç™‚ãƒ»ä»‹è·ãƒ»å¥åº·æƒ…å ±ã‚µã‚¤ãƒˆã§ã™ã€‚ OTEKOMACHI ã€Œï¼¯ï¼´ï¼¥ï¼«ï¼¯ï¼ï¼¡ï¼£ï¼¨ï¼©ï¼ˆå¤§æ‰‹å°ç”ºï¼‰ã€ã¯èªå£²æ–°èžãŒé‹å–¶ã™ã‚‹ã€åƒãå¥³æ€§ã‚’å¿œæ´ã™ã‚‹ã‚µã‚¤ãƒˆã§ã™ã€‚ idea market idea marketï¼ˆã‚¢ã‚¤ãƒ‡ã‚¢ ãƒžãƒ¼ã‚±ãƒƒãƒˆï¼‰ã€ã¯ã€èªå£²æ–°èžãŒé‹å–¶ã™ã‚‹ã‚¯ãƒ©ã‚¦ãƒ‰ãƒ•ã‚¡ãƒ³ãƒ‡ã‚£ãƒ³ã‚°ã®ã‚µã‚¤ãƒˆã§ã™ã€‚ ç¾Žè¡“å±•ãƒŠãƒ“ èªå£²æ–°èžãŒé‹å–¶ã™ã‚‹ç¾Žè¡“é¤¨ãƒ»åšç‰©é¤¨æƒ…å ±ã®ç·åˆãƒãƒ¼ã‚¿ãƒ«ãƒšãƒ¼ã‚¸ã§ã™ã€‚èªå£²æ–°èžä¸»å‚¬ã®å±•è¦§ä¼šã®ä»–ã€å…¨å›½ç¾Žè¡“é¤¨ã®æƒ…å ±ã‚’ç´¹ä»‹ã—ã¾ã™ã€‚ ç´¡ããƒ—ãƒã‚¸ã‚§ã‚¯ãƒˆ æ–‡åŒ–åºã€å®®å†…åºã€èªå£²æ–°èžç¤¾ã§è¡Œã†ã€Œç´¡ããƒ—ãƒã‚¸ã‚§ã‚¯ãƒˆã€å…¬å¼ã‚µã‚¤ãƒˆã€‚æ—¥æœ¬ç¾Žè¡“ã¨ä¼çµ±èŠ¸èƒ½ãªã©æ—¥æœ¬æ–‡åŒ–ã®é…åŠ›ã‚’ä¼ãˆã¾ã™ã€‚ èªå£²èª¿æŸ»ç ”ç©¶æ©Ÿæ§‹ æ±äº¬ã€åŒ—æµ·é“ã€æ±åŒ—ã€ä¸éƒ¨ã€åŒ—é™¸ã‚’æ‹ ç‚¹ã«ã€è‘—åãªè¬›å¸«ã‚’æ‹›ã„ãŸè¬›æ¼”ä¼šã‚„
stella_nf 2021/04/13
medical

disease

COVID-19

L452R
ãƒªãƒ³ã‚¯
1

ãŠçŸ¥ã‚‰ã›

ã‚‚ã£ã¨èªã‚€

å…¬å¼Twitter

@hatebu
æœ€æ–°ã®äººæ°—ã‚¨ãƒ³ãƒˆãƒªãƒ¼ã®é…ä¿¡

ã‚ãƒ¼ãƒœãƒ¼ãƒ‰ã‚·ãƒ§ãƒ¼ãƒˆã‚«ãƒƒãƒˆä¸€è¦§

jæ¬¡ã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

kå‰ã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

lã‚ã¨ã§èªã‚€

eã‚³ãƒ¡ãƒ³ãƒˆä¸€è¦§ã‚’é–‹ã

oãƒšãƒ¼ã‚¸ã‚’é–‹ã

è¨å®šã‚’å¤‰æ›´ã—ã¾ã—ãŸx

ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

ã‚¿ã‚°

é–¢é€£ã‚¿ã‚°ã§çµžã‚Šè¾¼ã‚€ (5)

L452Rã«é–¢ã™ã‚‹stella_nfã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (3)

ãŠçŸ¥ã‚‰ã›

ä»Šé€±ã®ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯æ•°ãƒ©ãƒ³ã‚ãƒ³ã‚°ï¼ˆ2024å¹´12æœˆç¬¬1é€±ï¼‰

æœˆé–“ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯æ•°ãƒ©ãƒ³ã‚ãƒ³ã‚°ï¼ˆ2024å¹´11æœˆï¼‰

ä»Šé€±ã®ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯æ•°ãƒ©ãƒ³ã‚ãƒ³ã‚°ï¼ˆ2024å¹´11æœˆç¬¬5é€±ï¼‰

å…¬å¼Twitter

ã‚ãƒ¼ãƒœãƒ¼ãƒ‰ã‚·ãƒ§ãƒ¼ãƒˆã‚«ãƒƒãƒˆä¸€è¦§

ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

å…¬å¼Twitter

ã¯ã¦ãªã®ã‚µãƒ¼ãƒ“ã‚¹

ã‚¿ã‚°

é–¢é€£ã‚¿ã‚°ã§çµžã‚Šè¾¼ã‚€ (5)

L452Rã«é–¢ã™ã‚‹stella_nfã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (3)

æ±äº¬éƒ½ ã‚¤ãƒ³ãƒ‰ã§è¦‹ã¤ã‹ã£ãŸå¤‰ç•°ã‚¦ã‚¤ãƒ«ã‚¹ã«ã‚ˆã‚‹ã‚¯ãƒ©ã‚¹ã‚¿ãƒ¼ç™ºç”Ÿ | NHKãƒ‹ãƒ¥ãƒ¼ã‚¹

éƒ½å†…ã§ã‚¤ãƒ³ãƒ‰ã®å¤‰ç•°ã‚¦ã‚¤ãƒ«ã‚¹5äººæ¤œå‡º 4äººã¯æ¸¡èˆªæ­´ãªã | NHKãƒ‹ãƒ¥ãƒ¼ã‚¹

ã€ç‹¬è‡ªã€‘ç±³ã§æµè¡Œã®å¤‰ç•°åž‹ã€æ—¥æœ¬äººã®ï¼–å‰²ã¯å…ç–«åŠ¹æžœä½Žä¸‹ã‹â€¦æ±å¤§ãªã©è§£æž : ç§‘å­¦ãƒ»ï¼©ï¼´ : ãƒ‹ãƒ¥ãƒ¼ã‚¹

ãŠçŸ¥ã‚‰ã›

ä»Šé€±ã®ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯æ•°ãƒ©ãƒ³ã‚­ãƒ³ã‚°ï¼ˆ2024å¹´12æœˆç¬¬1é€±ï¼‰

æœˆé–“ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯æ•°ãƒ©ãƒ³ã‚­ãƒ³ã‚°ï¼ˆ2024å¹´11æœˆï¼‰

ä»Šé€±ã®ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯æ•°ãƒ©ãƒ³ã‚­ãƒ³ã‚°ï¼ˆ2024å¹´11æœˆç¬¬5é€±ï¼‰

å…¬å¼Twitter

ã‚­ãƒ¼ãƒœãƒ¼ãƒ‰ã‚·ãƒ§ãƒ¼ãƒˆã‚«ãƒƒãƒˆä¸€è¦§

ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

å…¬å¼Twitter

ã¯ã¦ãªã®ã‚µãƒ¼ãƒ“ã‚¹

é–¢é€£ã‚¿ã‚°ã§çµžã‚Šè¾¼ã‚€ (5)

L452Rã«é–¢ã™ã‚‹stella_nfã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (3)

æ±äº¬éƒ½ ã‚¤ãƒ³ãƒ‰ã§è¦‹ã¤ã‹ã£ãŸå¤‰ç•°ã‚¦ã‚¤ãƒ«ã‚¹ã«ã‚ˆã‚‹ã‚¯ãƒ©ã‚¹ã‚¿ãƒ¼ç™ºç”Ÿ | NHKãƒ‹ãƒ¥ãƒ¼ã‚¹

éƒ½å†…ã§ã‚¤ãƒ³ãƒ‰ã®å¤‰ç•°ã‚¦ã‚¤ãƒ«ã‚¹5äººæ¤œå‡º 4äººã¯æ¸¡èˆªæ´ãªã | NHKãƒ‹ãƒ¥ãƒ¼ã‚¹

ã€ç‹¬è‡ªã€‘ç±³ã§æµè¡Œã®å¤‰ç•°åž‹ã€æ—¥æœ¬äººã®ï¼–å‰²ã¯å…ç–«åŠ¹æžœä½Žä¸‹ã‹â€¦æ±å¤§ãªã©è§£æž : ç§‘å¦ãƒ»ï¼©ï¼´ : ãƒ‹ãƒ¥ãƒ¼ã‚¹

ãŠçŸ¥ã‚‰ã›

ä»Šé€±ã®ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯æ•°ãƒ©ãƒ³ã‚ãƒ³ã‚°ï¼ˆ2024å¹´12æœˆç¬¬1é€±ï¼‰

æœˆé–“ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯æ•°ãƒ©ãƒ³ã‚ãƒ³ã‚°ï¼ˆ2024å¹´11æœˆï¼‰

ä»Šé€±ã®ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯æ•°ãƒ©ãƒ³ã‚ãƒ³ã‚°ï¼ˆ2024å¹´11æœˆç¬¬5é€±ï¼‰

å…¬å¼Twitter

ã‚ãƒ¼ãƒœãƒ¼ãƒ‰ã‚·ãƒ§ãƒ¼ãƒˆã‚«ãƒƒãƒˆä¸€è¦§

ã¯ã¦ãªãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

å…¬å¼Twitter

ã¯ã¦ãªã®ã‚µãƒ¼ãƒ“ã‚¹